NCT00004090View on ClinicalTrials.gov

Gemcitabine and Cisplatin in Treating Patients With Metastatic or Recurrent Solid Tumors

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 1999

Primary Completion Date

August 31, 2002

Study Completion Date

August 31, 2002

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

cisplatin

DRUG

gemcitabine hydrochloride

Trial Locations (2)

60611

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago

08901

Cancer Institute of New Jersey, New Brunswick

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Northwestern University

OTHER

NCT00004090 - Gemcitabine and Cisplatin in Treating Patients With Metastatic or Recurrent Solid Tumors | Biotech Hunter | Biotech Hunter